A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies

Serological assays have been widely used to detect anti-SARS-CoV-2 antibodies, which are generated from previous exposure to the virus or after vaccination. The presence of anti-SARS-CoV-2 Nucleocapsid antibodies was recently reported in patients´ urine using an in-house urine-based ELISA-platform,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Fernanda F., Bagno, Flávia F., Vassallo, Paula F., Oliveira-da-Silva, João A., Reis, Thiago A. R., Bandeira, Raquel S., Machado, Amanda S., Lage, Daniela P., Martins, Vivian T., Fernandes, Ana P., Christodoulides, Myron, Ravetti, Cecilia G., Nobre, Vandack, da Fonseca, Flávio G., Coelho, Eduardo A. F., Ludolf, Fernanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018619/
https://www.ncbi.nlm.nih.gov/pubmed/36927952
http://dx.doi.org/10.1038/s41598-023-31382-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018619/
https://www.ncbi.nlm.nih.gov/pubmed/36927952
http://dx.doi.org/10.1038/s41598-023-31382-5

Ejemplares similares